Mode
Text Size
Log in / Sign up

Presbyopia

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Presbyopia

108 trials tracked for Presbyopia: 14 in phase 3 or 4 and 4 with published results. The most-cited published study has 48 citations.

108Trials tracked
14Phase 3 & 4
0Recruiting
4With published results
Phase distribution
Phase 4 2 Phase 3 12 Phase 2 12 Other / NA 82
  1. Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia Completed · 48 cited
  2. Phase 3 An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-2) Completed · 17 cited
  3. Phase 3 An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-1) Completed · 16 cited
  4. Phase 3 A Study to Assess the Impact and Adverse Events of Topical Eyedrops of AGN-190584 on Night-driving Performance in Participants, 40 to 55 Years of Age Completed · 8 cited
  5. Phase 4 Clinical Investigation of the Vision-R800 Device. Completed
  6. Phase 4 The Development of New Functions of Esculin and Digitalis Glycosides Eye Drops: A Study on the Treatment of Presbyopia Completed
Show 44 more trials
  1. Phase 3 A Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia Completed
  2. Phase 3 A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice Daily Completed
  3. Phase 3 Safety and Efficacy Study BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic or Pseudophakic Presbyopia Completed
  4. Phase 3 Safety and Efficacy of Nyxol Eye Drops as a Single Agent and With Adjunctive Low-Dose Pilocarpine Eye Drops in Subjects With Presbyopia Completed
  5. Phase 3 An Evaluation of the Safety of CSF-1 in Presbyopic Subjects Completed
  6. Phase 3 Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of Presbyopia Completed
  7. Phase 3 Phase 3 Efficacy Study of LNZ100 & LNZ101 for the Treatment of Presbyopia Completed
  8. Phase 3 Phase 3 Safety Study of LNZ100 and LNZ101 for the Treatment of Presbyopia Subjects Completed
  9. Phase 2 Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With Presbyopia Completed
  10. Phase 2 Safety and Efficacy of AGN-199201 and AGN-190584 in Patients With Presbyopia Completed
  11. Phase 2 Safety and Efficacy Study of BRIMOCHOL™, BRIMOCHOL™ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia Completed
  12. Phase 2 A Study of Safety and Efficacy of UNR844 Chloride (UNR844-Cl) Eye Drops in Subjects With Presbyopia. Completed
  13. Phase 2 A Multi-Center, Double-Masked Evaluation of the Efficacy and Safety of CSF-1 in the Treatment of Presbyopia Completed
  14. Phase 2 A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia Completed
  15. Phase 2 Evaluation of the Safety and Effectiveness of Aceclidine/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of Presbyopia Completed
  16. Phase 2 A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia Completed
  17. Phase 2 A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia Completed
  18. Phase 2 A Study of the Concurrent Use of AGN-190584 and AGN-199201 in Participants With Presbyopia Completed
  19. Phase 2 Evaluation of the Safety and Effectiveness of Aceclidine (LNZ101) and Aceclidine + Brimonidine (LNZ100) in the Treatment of Presbyopia Completed
  20. Phase 2 Study Assessing the Efficacy and Safety of STN1013600 Ophthalmic Solution 0.1% and 0.3% Compared With Placebo in Subjects With Presbyopia Completed
  21. N/A Comparison of a Multifocal Contact Lens to a Traditional Multifocal Contact Lens Completed
  22. N/A Comparison of Two Soft Bifocal Contact Lenses Completed
  23. N/A Performance Evaluation of Different Daily Disposable Multifocal Contact Lenses Completed
  24. N/A Silicone Hydrogel Contact Lens Clinical and Comfort Benefits With a Multi-Purpose Disinfecting Solution Completed
  25. N/A Tecnis ZLB00 & Symfony Intraocular Lens Combination Outcomes Completed
  26. N/A Monofocal IOL Visual Outcomes When Targeting Mini Monovision Completed
  27. N/A Prospective Study of Lens Performance of a Monthly Replacement Lens at Two Weeks and Four Weeks Completed
  28. N/A Clinical Performance of a Phakic Intraocular Lens (IOL) Completed
  29. N/A Vivity IOL: Emmetropia Compared to Monovision. Completed
  30. N/A Clinical Evaluation of Two New Silicone Hydrogel Multifocal Products Completed
  31. N/A Clinical Validation Study of Comfilcon A Multifocal Toric Contact Lenses Completed
  32. N/A Assessing the Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses Completed
  33. N/A Evaluating the Success of Habitual Multifocal Wearers When Refit With a New Lens Design Completed
  34. N/A Safety and Effectiveness Study of the AcuFocus Corneal Inlay ACI 7000PDT in Presbyopes Completed
  35. N/A Clinical Evaluation of the Safety and Efficacy of a New Multifocal Contact Lens Completed
  36. N/A A Dispensing Clinical Trial of Comfilcon A Extended Range Multifocal Lenses Completed
  37. N/A Clinical Assessment of a Multifocal Contact Lens for People Who Use Reading Glasses Only Completed
  38. N/A Post Approval Study of the AcrySof® IQ ReSTOR® Toric IOLs Completed
  39. N/A Multifocal High ADD Contact Lens Proof of Concept Trial Completed
  40. N/A Evaluation of Soft Multifocal Lenses in Presbyopic Previous Contact Lens Wearers Completed
  41. N/A Presbyopia Screening by Community Health Worker in Bangladesh Completed
  42. N/A Clinical Evaluation of Investigational Multifocal Toric Contact Lenses Completed
  43. N/A Long Term Follow-up of the VisAbility™ Micro Insert System for Presbyopic Patients Completed
  44. N/A Evaluation of an Investigational Multifocal Lens Completed

Showing the 50 most-cited and recently-updated of 108 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.